Monoclonal anti-acetylcholine receptor antibodies can cause experimental myasthenia

David P Richman, Christopher M. Gomez, Phillip W. Berman, Steven A. Burres, Frank W. Fitch, Barry G W Arnason

Research output: Contribution to journalArticlepeer-review

84 Scopus citations


Myasthenie gravis (MG) is a disease which occurs as a consequence of an autoimmune response directed against the nicotinic acetylcholine receptor (AChR) of the myoneural junction1-3. Antisera raised against complex antigens such as AChR comprise a mixture of antibodies reactive with various determinants on the antigen molecule. The antibodies against any single determinant may be of several immunoglobulin classes and idiotypes. Antibodies produced by cloned lymphocyte-myeloma hybridoma cell lines have provided a way of analysing the diverse components making up a polyclonal antiserum4 and assessing the relative contribution made by each to the overall immune reaction in vivo5,6. We have applied this technique to the investigation of the autoimmune response in MG. We demonstrate here that certain monoclonal anti-Torpedo AChR antibodies, when injected intravenously into normal rats, induce an acute myasthenie syndrome. Thus binding of a single molecular species of antibody reactive with a single antigenic determinant can result in all of the manifestations of an autoimmune disease.

Original languageEnglish (US)
Pages (from-to)738-739
Number of pages2
Issue number5774
StatePublished - 1980
Externally publishedYes

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Monoclonal anti-acetylcholine receptor antibodies can cause experimental myasthenia'. Together they form a unique fingerprint.

Cite this